Docetaxel, Oxaliplatin, and 5-Fluorouracil (DOF) in Metastatic and Unresectable Gastric/Gastroesophageal Junction Adenocarcinoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The Oncologist
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Docetaxel, Oxaliplatin, and 5-Fluorouracil (DOF) in Metastatic and Unresectable Gastric/Gastroesophageal Junction Adenocarcinoma: A Phase II Study With Long-Term Follow-Up
Oncologist 2019 May 28;[EPub Ahead of Print], AJ Rosenberg, A Rademaker, HS Hochster, T Ryan, T Hensing, V Shankaran, L Baddi, D Mahalingam, MF Mulcahy, AB BensonFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.